Topic Editors

Department of Environmental Biology, University of Rome, La Sapienza, Rome, Italy
Dipartimento di Scienze della Vita, della Salute e delle Professioni Sanitarie, Università degli Studi Link, Rome, Italy

Exploring the Cytotoxic and Antioxidant Potential of Plant Extracts

Abstract submission deadline
30 April 2026
Manuscript submission deadline
30 June 2026
Viewed by
917

Topic Information

Dear Colleagues,

It is a great honor for us to serve as Topic Editors for the Topic “Exploring the Cytotoxic and Antioxidant Potential of Plant Extracts”. In recent years, pharmacological research has directed its attention to studying the potential biological activities of plant extracts, given the increasing utilization of plants for treating several ailments worldwide and since they are generally considered as safer and possessing minor side effects compared to synthetic drugs. In particular, there is now an outstanding number of studies on the cytotoxic and antioxidant effects of plant extracts. We seek to further underline the importance of these studies by publishing new research or review articles on this Topic. There are no limitations on the type of plant, extracts, or assays used, but phytochemical analyses must fully explain the positive or negative results of the plant extracts from a phytochemical standpoint. We look forward to receiving your papers.

Dr. Claudio Frezza
Dr. Manuela Cipoletti
Topic Editors

Keywords

  • plant extracts
  • phytochemical analysis
  • cytotoxic activities
  • antioxidant activities
  • phytotherapy
  • ethnobotany

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Molecules
molecules
4.6 8.6 1996 16.1 Days CHF 2700 Submit
Plants
plants
4.1 7.6 2012 17.7 Days CHF 2700 Submit
Toxins
toxins
4.0 8.2 2009 18.4 Days CHF 2700 Submit
Antioxidants
antioxidants
6.6 12.4 2012 17.4 Days CHF 2900 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
28 pages, 1659 KB  
Review
The Potential Therapeutic Applications of Natural Products in the Oxidative Stress-Related MVA Pathway: Focus on HMGCR
by Yu-Ning Teng
Antioxidants 2025, 14(8), 1001; https://doi.org/10.3390/antiox14081001 - 16 Aug 2025
Viewed by 459
Abstract
This review explores the therapeutic promise of natural compounds in modulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), a key enzyme in cholesterol synthesis. HMGCR dysregulation is implicated in dyslipidemia, cardiovascular disease, and cancer, conditions linked to oxidative stress. While statins inhibit HMGCR, their side effects [...] Read more.
This review explores the therapeutic promise of natural compounds in modulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), a key enzyme in cholesterol synthesis. HMGCR dysregulation is implicated in dyslipidemia, cardiovascular disease, and cancer, conditions linked to oxidative stress. While statins inhibit HMGCR, their side effects necessitate exploring alternatives. The review highlights various natural compounds—flavonoids, phenolic acids, stilbenes, and herbal formulations—with HMGCR-modulating and antioxidant capabilities. In vitro and in vivo studies suggest these compounds offer a promising avenue for treating HMGCR-related conditions. Synergistic effects are observed when combining natural products with statins, hinting at combination therapies that could lower statin dosages and reduce adverse effects. Natural HMGCR modulators hold therapeutic promise but face hurdles like limited in vivo data, regulatory issues, variability in composition, potential drug interactions, and safety concerns. Future research must prioritize comprehensive mechanistic studies, standardized preparations, and well-designed clinical trials. Overcoming these challenges through rigorous science is essential for integrating natural HMGCR modulators into clinical practice and improving patient outcomes in a safe and effective manner. Specifically, clinical trials should consider combination therapies and comparison with standard treatments like statins. More research is also needed on optimal dosages and treatment regimens. Full article
Show Figures

Figure 1

Back to TopTop